Found: 29
Select item for more details and to access through your institution.
Differential transactivation by the androgen receptor in prostate cancer cells.
- Published in:
- Prostate, 1998, v. 36, n. 4, p. 256, doi. 10.1002/(SICI)1097-0045(19980901)36:4<256::AID-PROS7>3.0.CO;2-D
- By:
- Publication type:
- Article
Fetuin-A Promotes 3-Dimensional Growth in LNCaP Prostate Cancer Cells by Sequestering Extracellular Vesicles to Their Surfaces to Act as Signaling Platforms.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 7, p. 4031, doi. 10.3390/ijms23074031
- By:
- Publication type:
- Article
Human homolog of Drosophila Hairy and enhancer of split 1, Hes1, negatively regulates δ-catenin (CTNND2) expression in cooperation with E2F1 in prostate cancer.
- Published in:
- Molecular Cancer, 2010, v. 9, p. 304, doi. 10.1186/1476-4598-9-304
- By:
- Publication type:
- Article
Epididymis-specific lipocalin promoters.
- Published in:
- Asian Journal of Andrology, 2007, v. 9, n. 4, p. 515, doi. 10.1111/j.1745-7262.2007.00300.x
- By:
- Publication type:
- Article
Activation of NF-kappa B Signaling Promotes Growth of Prostate Cancer Cells in Bone.
- Published in:
- PLoS ONE, 2013, v. 8, n. 4, p. 1, doi. 10.1371/journal.pone.0060983
- By:
- Publication type:
- Article
Loss of the Urothelial Differentiation Marker FOXA1 Is Associated with High Grade, Late Stage Bladder Cancer and Increased Tumor Proliferation.
- Published in:
- PLoS ONE, 2012, v. 7, n. 5, p. 1, doi. 10.1371/journal.pone.0036669
- By:
- Publication type:
- Article
Foxa1 and Foxa2 Interact with the Androgen Receptor to Regulate Prostate and Epididymal Genes Differentially.
- Published in:
- Annals of the New York Academy of Sciences, 2005, v. 1061, n. 1, p. 77, doi. 10.1196/annals.1336.009
- By:
- Publication type:
- Article
Use of the Probasin Promoter ARR[sub 2]PB to Express Bax in Androgen Receptor-Positive Prostate....
- Published in:
- JNCI: Journal of the National Cancer Institute, 2001, v. 93, n. 17, p. 1314, doi. 10.1093/jnci/93.17.1314
- By:
- Publication type:
- Article
Lysosome‐dependent FOXA1 ubiquitination contributes to luminal lineage of advanced prostate cancer.
- Published in:
- Molecular Oncology, 2023, v. 17, n. 10, p. 2126, doi. 10.1002/1878-0261.13497
- By:
- Publication type:
- Article
Genomic organization and chromosomal localization of the murine epididymal retinoic acid-binding protein (mE-RABP) gene.
- Published in:
- Molecular Reproduction & Development, 1998, v. 50, n. 4, p. 387, doi. 10.1002/(SICI)1098-2795(199808)50:4<387::AID-MRD2>3.0.CO;2-E
- By:
- Publication type:
- Article
Prostatic osteopontin expression is associated with symptomatic benign prostatic hyperplasia.
- Published in:
- Prostate, 2020, v. 80, n. 10, p. 731, doi. 10.1002/pros.23986
- By:
- Publication type:
- Article
NF-κB and androgen receptor variant 7 induce expression of SRD5A isoforms and confer 5ARI resistance.
- Published in:
- Prostate, 2016, v. 76, n. 11, p. 1004, doi. 10.1002/pros.23195
- By:
- Publication type:
- Article
NF-κB and androgen receptor variant expression correlate with human BPH progression.
- Published in:
- Prostate, 2016, v. 76, n. 5, p. 491, doi. 10.1002/pros.23140
- By:
- Publication type:
- Article
Activation of Wnt/β-catenin signaling in a subpopulation of murine prostate luminal epithelial cells induces high grade prostate intraepithelial neoplasia.
- Published in:
- Prostate, 2014, v. 74, n. 15, p. 1506, doi. 10.1002/pros.22868
- By:
- Publication type:
- Article
Skp2 regulates androgen receptor through ubiquitin-mediated degradation independent of Akt/mTOR pathways in prostate cancer.
- Published in:
- Prostate, 2014, v. 74, n. 4, p. 421, doi. 10.1002/pros.22763
- By:
- Publication type:
- Article
Mash1 expression is induced in neuroendocrine prostate cancer upon the loss of Foxa2.
- Published in:
- Prostate, 2013, v. 73, n. 6, p. 582, doi. 10.1002/pros.22598
- By:
- Publication type:
- Article
Characterization of cis elements of the probasin promoter necessary for prostate-specific gene expression.
- Published in:
- Prostate, 2010, v. 70, n. 9, p. 934, doi. 10.1002/pros.21128
- By:
- Publication type:
- Article
Activation of β-Catenin in mouse prostate causes HGPIN and continuous prostate growth after castration.
- Published in:
- Prostate, 2009, v. 69, n. 3, p. 249, doi. 10.1002/pros.20877
- By:
- Publication type:
- Article
Neuroendocrine differentiation in the 12T-10 transgenic prostate mouse model mimics endocrine differentiation of pancreatic beta cells.
- Published in:
- Prostate, 2008, v. 68, n. 1, p. 50, doi. 10.1002/pros.20650
- By:
- Publication type:
- Article
Expression and role of Foxa proteins in prostate cancer.
- Published in:
- Prostate, 2006, v. 66, n. 10, p. 1013, doi. 10.1002/pros.20299
- By:
- Publication type:
- Article
Murine androgen‐independent neuroendocrine carcinoma promotes metastasis of human prostate cancer cell line LNCaP.
- Published in:
- Prostate, 2006, v. 66, n. 5, p. 536, doi. 10.1002/pros.20369
- By:
- Publication type:
- Article
Expression of Foxa transcription factors in the developing and adult murine prostate.
- Published in:
- Prostate, 2005, v. 62, n. 4, p. 339, doi. 10.1002/pros.20131
- By:
- Publication type:
- Article
Prostate-specific antitumor activity by probasin promoter-directed p202 expression (Yong Wen, Dipak Giri, and Duen-Hwa Yan contributed equally to this work.).
- Published in:
- Molecular Carcinogenesis, 2003, v. 37, n. 3, p. 130, doi. 10.1002/mc.10129
- By:
- Publication type:
- Article
Transcriptomic analysis of benign prostatic hyperplasia identifies critical pathways in prostatic overgrowth and 5‐alpha reductase inhibitor resistance.
- Published in:
- Prostate, 2024, v. 84, n. 5, p. 441, doi. 10.1002/pros.24661
- By:
- Publication type:
- Article
Glucocorticoids are induced while dihydrotestosterone levels are suppressed in 5‐alpha reductase inhibitor treated human benign prostate hyperplasia patients.
- Published in:
- Prostate, 2022, v. 82, n. 14, p. 1378, doi. 10.1002/pros.24410
- By:
- Publication type:
- Article
The prostaglandin pathway is activated in patients who fail medical therapy for benign prostatic hyperplasia with lower urinary tract symptoms.
- Published in:
- Prostate, 2021, v. 81, n. 13, p. 944, doi. 10.1002/pros.24190
- By:
- Publication type:
- Article
Slug regulates E-cadherin repression via p19Arf in prostate tumorigenesis.
- Published in:
- Molecular Oncology, 2014, v. 8, n. 7, p. 1355, doi. 10.1016/j.molonc.2014.05.006
- By:
- Publication type:
- Article
SPARCL1 suppresses metastasis in prostate cancer.
- Published in:
- Molecular Oncology, 2013, v. 7, n. 6, p. 1019, doi. 10.1016/j.molonc.2013.07.008
- By:
- Publication type:
- Article
How to Use Animal Models to Study Prostate Cancer.
- Published in:
- AUANews, 2011, v. 16, n. 11, p. 17
- By:
- Publication type:
- Article